You can view the research column published every month by SMC Laboratories.
2025.02.02
Results of drug efficacy evaluation studies using the NASH model_Microbiome
Today, we would like to introduce to you a study published by our client, MRM Health, in which they used our p…
READ MORE
2025.02.02
Preclinical data in NASH Mouse Model_β-glucans
Today’s topic is Effective and Safe Nutritional Supplements for NASH Management. I am writing you to int…
READ MORE
2025.02.02
The STAM model as a model for hepatocellular carcinoma
We would like to introduce today a NASH-HCC model from SMC Laboratories (“STAMTM mice”) for your oncology R&a…
READ MORE
2025.02.02
Research article published in Cells
We would like to introduce a new publication using the STAM™ model presented by our client NeuroVive in Cells….
READ MORE
2025.02.02
HCC model STAM in review paper [Liu et. al Hepatoma Research 2020;6:7]
STAM™ was originally developed as a NASH model, but with a 100% incidence of HCC as early as 20 weeks, it is a…
READ MORE
2025.02.02
Translational relevance in STAM (NASH-HCC)
One factor that must be considered when selecting models for pre-clinical research is translatability. As of J…
READ MORE
2025.02.02
Update on the clinical relevance of STAM model
One of our clients FDA-National Center for Toxicological Research (NCTR) has published the results of a study …
READ MORE
2025.02.02
One of our clients published preclinical data on NASH-fibrosis on Biochemistry
We announced that a study in the STAM™ mouse model of NASH performed by SMC Laboratories Inc. has been publish…
READ MORE
2025.02.02
Update on the clinical relevance of STAM model
We announced that Dr. Karin’s group has presented the results of a study using STAM TM model in PNAS. Title: &…
READ MORE
2025.02.02
One of our clients published preclinical data on NASH-fibrosis on Hepatology Communications
We announced that a study in the STAM™ mouse model of NASH performed by SMC Laboratories Inc. has been publish…
READ MORE
